Health-related quality of life and disease activity in rheumatoid arthritis

Journal of Research in Medical Sciences

Volumn 16, Issue 7, 2011, Pages 897-903

  Alishiri, Gholam Hossein ^a   Bayat, Noushin ^a   Salimzadeh, Ahmad ^a   Salari, Amirhossein ^a   Hosseini, Seyed Morteza ^a   Rahimzadeh, Shadi ^a,b   Assari, Shervin ^c  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Universal Network for Health Information Dissemination and Exchange (UNHIDE)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Disease activity score; Health related quality of life; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PHYSICAL CAPACITY; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SHORT FORM 36;

EID: 80052876422     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Arvidson NG. Disease activity in rheumatoid arthritis: studies on interleukin-6, tumour necrosis factor alpha, monocyte activity, acute phase markers, glucocorticoids, and disability. Uppsala: Acta Universitatis Upsaliensis; 2003. p. 1248-1288.
2. Rintelen B, Sautner J, Haindl PM, Andel I, Maktari A, Leeb BF. Comparison of three rheumatoid arthritis disease activity scores in clinical routine. Scand J Rheumatol 2009; 38(5): 336-341.
3. Salaffi F, Cimmino MA, Leardini G, Gasparini S, Grassi W. Disease activity assessment of rheumatoid arthritis in daily practice: validity, internal consistency, reliability and congruency of the Disease Activity Score including 28 joints (DAS28) compared with the Clinical Disease Activity Index (CDAI). Clin Exp Rheumatol 2009; 27(4): 552-559.
4. Castrejon I, Ortiz AM, Toledano E, Castaneda S, Garcia-Vadillo A, Patino E, et al. Estimated cutoff points for the 28-joint disease activity score based on C-reactive protein in a longitudinal register of early arthritis. J Rheumatol 2010; 37(7): 1439-1443.
5. Pincus T, Yazici Y, Bergman MJ. RAPID3, an index to assess and monitor patients with rheumatoid arthritis, without formal joint counts: similar results to DAS28 and CDAI in clinical trials and clinical care. Rheum Dis Clin North Am 2009; 35(4): 773-778, viii.
6. Fransen J, van Riel PL. The Disease Activity Score and the EULAR response criteria. Clin Exp Rheumatol 2005; 23(5 Suppl 39): S93-S99.
7. Pincus T. Can RAPID3, an index without formal joint counts or laboratory tests, serve to guide rheumatologists in tight control of rheumatoid arthritis in usual clinical care? Bull NYU Hosp Jt Dis 2009; 67(3): 254-266.
8. Van der Heijde DM, Jacobs JW. The original DAS and the DAS28 are not interchangeable: comment on the articles by Prevoo et al. Arthritis Rheum 1998; 41(5): 942-945.
9. Van Leeuwen MA, Van der Heijde DM, van Rijswijk MH, Houtman PM, van Riel PL, van de Putte LB, et al. Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants. J Rheumatol 1994; 21(3): 425-429.
10. Guillemin F, Briancon S, Pourel J. Functional disability in rheumatoid arthritis: two different models in early and established disease. J Rheumatol 1992; 19(3): 366-369.
11. Ritchie DM, Boyle JA, McInnes JM, Jasani MK, Dalakos TG, Grieveson P, et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968; 37(147): 393-406.
12. Eichler HG, Mavros P, Geling O, Hunsche E, Kong S. Association between health-related quality of life and clinical efficacy endpoints in rheumatoid arthritis patients after four weeks treatment with anti-inflammatory agents. Int J Clin Pharmacol Ther 2005; 43(5): 209-216.
13. Assari S. Ten conditions Ten Morbidity measures. Dev World Epidemiol 2010; 1(1): 40-49.
14. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31(3): 315-324.
15. Vittecoq O, Pouplin S, Krzanowska K, Jouen-Beades F, Menard JF, Gayet A, et al. Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three-year prospective study in community-recruited patients. Rheumatology (Oxford) 2003; 42(8): 939-946.
16. Stucki G, Liang MH, Stucki S, Bruhlmann P, Michel BA. A self-administered rheumatoid arthritis disease activity index (RADAI) for epidemiologic research. Psychometric properties and correlation with parameters of disease activity. Arthritis Rheum 1995; 38(6): 795-798.
17. Van der Heijde DM, 't Hof MA, van Riel PL, Theunisse LA, Lubberts EW, van Leeuwen MA, et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 1990; 49(11): 916-920.
18. Van Riel PL, Van Gestel AM, Van de Putte LB. Development and validation of response criteria in rheumatoid arthritis: steps towards an international consensus on prognostic markers. Br J Rheumatol 1996; 35 Suppl 2: 4-7.
19. Ware JE, Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol 1998; 51(11): 903-912.
20. Talamo J, Frater A, Gallivan S, Young A. Use of the short form 36 (SF36) for health status measurement in rheumatoid arthritis. Br J Rheumatol 1997; 36(4): 463-469.
21. Montazeri A, Goshtasebi A, Vahdaninia M, Gandek B. The Short Form Health Survey (SF-36): translation and validation study of the Iranian version. Qual Life Res 2005; 14(3): 875-882.
22. Zargooshi J. Quality of life of Iranian kidney donors. J Urol 2001; 166(5): 1790-1799.
23. Alishiri GH, Bayat N, Fathi AA, Tavallaii SA, Assari S, Moharamzad Y. Logistic regression models for predicting physical and mental health-related quality of life in rheumatoid arthritis patients. Mod Rheumatol 2008; 18(6): 601-608.
24. Dadoniene J, Stropuviene S, Venalis A, Boonen A. High work disability rate among rheumatoid arthritis patients in Lithuania. Arthritis Rheum 2004; 51(3): 433-439.
25. Adebajo AO, Reid DM. The pattern of rheumatoid arthritis in West Africa and comparison with a cohort of British patients. Q J Med 1991; 80(292): 633-640.
26. Dadoniene J, Uhlig T, Stropuviene S, Venalis A, Boonen A, Kvien TK. Disease activity and health status in rheumatoid arthritis: a case-control comparison between Norway and Lithuania. Ann Rheum Dis 2003; 62(3): 231-235.
27. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23(2): 137-145.
28. Van Der Heijde DM, Van't Hof MA, Van Riel PL, Van Leeuwen MA, Van Rijswijk MH, Van De Putte LB. Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis. Ann Rheum Dis 1992; 51(2): 177-181.
29. Davis MJ, Dawes PT, Fowler PD, Sheeran TP, Shadforth MF, Ziade F, et al. Comparison and evaluation of a disease activity index for use in patients with rheumatoid arthritis. Br J Rheumatol 1990; 29(2): 111-115.
30. Chikanza IC, Stein M, Lutalo S, Gibson T. The clinical, serologic and radiologic features of rheumatoid arthritis in ethnic black Zimbabwean and British Caucasian patients. J Rheumatol 1994; 21(11): 2011-2015.
31. Bell MJ, Bombardier C, Tugwell P. Measurement of functional status, quality of life, and utility in rheumatoid arthritis. Arthritis Rheum 1990; 33(4): 591-601.
32. Hagen KB, Smedstad LM, Uhlig T, Kvien TK. The responsiveness of health status measures in patients with rheumatoid arthritis: comparison of disease-specific and generic instruments. J Rheumatol 1999; 26(7): 1474-1480.
33. Suurmeijer TP, Waltz M, Moum T, Guillemin F, van Sonderen FL, Briancon S, et al. Quality of life profiles in the first years of rheumatoid arthritis: results from the EURIDISS longitudinal study. Arthritis Rheum 2001; 45(2): 111-121.
34. Inoue E, Yamanaka H, Hara M, Tomatsu T, Kamatani N. Comparison of Disease Activity Score (DAS)28-erythrocyte sedimentation rate and D. Ann Rheum Dis 2007; 66(3): 407-409.
35. Matsui T, Kuga Y, Kaneko A, Nishino J, Eto Y, Chiba N, et al. Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan. Ann Rheum Dis 2007; 66(9): 1221-1226.
36. Assari SH, Moghani Lankarani M, Montazeri A, Soroush MR, Mousavi B. Are generic and disease-specific health related quality of life correlated? The case of chronic lung disease due to sulfur mustard. JRMS 2007; 14(5): 285-290.
37. Aslani J, Mirzamani SM, Abadi A, Farahani M, Moghani Lankarani M, Assari SH. Health-Related Quality of Life in Chronic Obstructive Pulmonary Disease: Are Disease-Specific and Generic Quality of Life Measures Correlated? Tanaffos Respiration Journal 2008; 7(2): 28-35.
38. Birtane M, Kabayel DD, Uzunca K, Unlu E, Tastekin N. The relation of hand functions with radiological damage and disease activity in rheumatoid arthritis. Rheumatol Int 2008; 28(5): 407-412.
39. Irvine S, Capell HC. Great expectations of modern RA treatment. Ann Rheum Dis 2005; 64(9): 1249-1251.